市場調查報告書
商品編碼
1383420
2030 年劑量監測市場預測:按產品類型、應用、最終用戶和地區分類的全球分析Dose Monitoring Market Forecasts to 2030 - Global Analysis By Product Type (Hardware, Software and Services ), Application (Radiography, Radiotherapy and Other Applications), End User and By Geography |
根據Stratistics MRC預測,2023年全球劑量監測市場規模將達到43.6億美元,預計2030年將達到79.7億美元,預測期內年複合成長率為9.0%。
在各種醫療保健環境中檢測、追蹤和控制輸送給患者的輻射量和藥物的過程稱為劑量監測。確保患者安全、最佳化治療結果、遵守法規標準都取決於劑量監測。劑量監測是指準確檢測和追蹤診所、醫院和其他醫療機構對病人給藥的藥物量。它不僅可以確保患者給藥正確的劑量,還有助於防止用藥錯誤並追蹤藥物劑量,以確保患者的安全和依從性。
影像技術的開拓是劑量監測市場擴大的主要因素。由於這些技術進步,醫療診斷和治療計劃領域正在經歷重大變革。 電腦斷層掃描、MRI 掃描和 PET 掃描等先進顯像模式可提供更好的影像品質和診斷準確性,在現代醫療保健中變得越來越重要。然而,其中許多技術,尤其是多層 CT 掃描儀和介入放射學程序,使患者暴露在高劑量的電離輻射下。因此,迫切需要準確的劑量監測以確保病人安全。劑量監測解決方案對於追蹤和給藥這些先進影像處理中的輻射劑量至關重要。
實施劑量監測技術成本高。這包括購買、配置和認證必要的設備和應用程式的成本,以及培訓醫務人員如何有效使用該技術的成本。然而,一些醫療機構,特別是預算有限的小型機構,可能會因為初期成本高昂而猶豫是否實施這些解決方案。因此,高昂的初始成本是市場擴張的主要障礙。
給藥監測有多種可能性,因為先進的資料分析提供了靈活的方法來提高病人安全、治療效果和業務效率。資料分析可能是徹底改變劑量監測應用和利用的關鍵因素,特別是在法規和醫療保健提供者繼續強調輻射安全的重要性的情況下。這些系統可擷取放射治療和診斷成像期間輻射暴露的詳細資料。使用高級資料分析對這些資料進行處理和分析,以提供富有洞察力的結論。這些東西正在增加市場需求。
劑量監測市場非常難以改變。這主要是由於在醫療保健環境中實施新程序和技術時遇到的困難。劑量監測的整合有可能脫離醫療保健工作者和機構經常遵循的既定工作流程。如果某些放射腫瘤科和醫學部門擔心變革會影響其日常業務,他們可能會抵制變革。此外,抗藥性可能與建立和維護劑量監測計劃的困難有關。當新技術被引入時,員工需要接受特殊培訓,這在過渡時期可能會很費力。
此次疫情增加了對醫學影像的需求,特別是用於監測和診斷 COVID-19 病例的 CT 和胸部 X 光檢查。診斷影像服務需求的增加直接影響了對劑量監測解決方案的需求,以確保患者接受適當的劑量,同時最大限度地減少不必要的暴露。疫情推動了劑量監測軟體等數位健康技術的採用。隨著醫療保健提供者尋求遠端患者資料管理和監測解決方案,數位劑量監測工具的價值不斷增加。
預計軟體產業將佔據最大佔有率。劑量監測軟體是指旨在追蹤、管理和分析給藥患者的輻射和藥物劑量的專用程序和應用程式。該軟體對於確保準確的劑量管理、降低風險和改善患者治療效果至關重要。它幫助醫學物理學家和放射腫瘤學家最佳化治療方法,確保成功靶向腫瘤,同時最大限度地減少對附近健康組織的傷害。該軟體的即時監測和調整功能使放射治療更加準確。
診斷中心部門預計在預測期內將出現良好的成長。劑量監測系統透過將輻射暴露限制在安全水平來幫助醫療保健專業人員降低患者健康風險。劑量監測解決方案透過確保按照建議的劑量水平和安全程序進行診斷成像,有助於遵守這些法規。透過簡化資料收集和報告流程,劑量監測軟體可以提高診斷中心的效率。它不僅確保輻射安全,而且還使醫務人員能夠騰出時間專注於病患照護。
在估計期間,北美佔據了最大的市場佔有率。劑量監測市場的主要參與者是美國和加拿大。該地區擁有強大的醫療保健系統和尖端醫療技術的高採用率。北美醫療保健組織和提供者是實施尖端醫療技術的先驅。劑量監測在該領域非常重要,無論是對於醫院的藥物給藥還是對於癌症治療中使用的放射治療。隨著法規的收緊和技術的進步,該地區將繼續成為支持全球劑量監測產業的主要力量。
由於其先進的醫療基礎設施和嚴格的法規環境,預計歐洲在預測期內將實現盈利成長。由於歐洲醫療保健配合措施提供高品質的患者照護,因此劑量監測解決方案的需求量很大。更嚴格的立法和對病人安全的重視鼓勵使用最尖端科技進行劑量監測。德國是歐洲經濟強國之一,擁有發達的醫療設施和完善的醫療保健體系。
According to Stratistics MRC, the Global Dose Monitoring Market is accounted for $4.36 billion in 2023 and is expected to reach $7.97 billion by 2030 growing at a CAGR of 9.0% during the forecast period. The process of measuring, tracking, and controlling the amount of radiation or medication given to patients in different healthcare settings is known as dose monitoring. Ensuring patient safety, optimizing treatment outcomes, and adhering to regulatory standards all depend on it. The precise measurement and tracking of drug doses administered to patients in clinics, hospitals, or other healthcare facilities is referred to as dose monitoring. In addition to guaranteeing that patients receive the right doses, this also helps to prevent medication errors and keeps track of medication administration for patient safety and compliance.
Developments in imaging technology are a major factor in the market expansion for dose monitoring. The field of medical diagnosis and treatment planning has seen a substantial transformation as a result of these technological advancements. Advanced imaging modalities like CT, MRI, and PET scans, which provide better image quality and diagnostic accuracy, are becoming increasingly important in modern healthcare. However, a lot of these techniques expose patients to higher doses of ionizing radiation, especially multi-slice CT scanners and interventional radiology procedures. Therefore, accurate dose monitoring is urgently required to guarantee patient safety. In order to track and manage the radiation doses administered during these advanced imaging procedures, dose monitoring solutions have become essential.
Dose-monitoring technology implementation can be costly. This covers the cost of purchasing, setting up, and certifying the required gear and applications, in addition to the cost of educating medical staff on how to use the technology efficiently. However, some healthcare facilities, especially smaller ones with tighter budgets, may be discouraged from implementing these solutions due to the substantial upfront costs. Therefore, high initial cost is a significant barrier to market expansion.
Dose monitoring has a lot of potential because advanced data analytics offer a flexible way to improve patient safety, treatment efficacy, and operational efficiency. Data analytics can be a key factor in revolutionizing the application and utilization of dose monitoring, particularly as regulators and healthcare providers continue to stress the significance of radiation safety. These systems capture minute details regarding radiation exposure during radiation therapy and diagnostic imaging. This data can be processed and analyzed using advanced data analytics to provide insightful conclusions. These factors enhance market demand.
The market for dose monitoring is highly resistant to change, which is mostly caused by the difficulties that come with introducing new procedures and technology in healthcare settings. Integrating dose monitoring may break out of the well-established workflows that healthcare practitioners and institutions frequently follow. Particular departments dealing with radiation oncology and radiology may be resistant to change if they worry it will affect their daily operations. Furthermore, resistance may be associated with worries about how difficult it will be to set up and maintain dose monitoring programs. Staff may need extra training when new technologies are introduced, and this transitional period may be burdensome.
Due to the pandemic, there was an increase in the need for medical imaging, particularly CT and chest X-rays, which were necessary for COVID-19 case monitoring and diagnosis. The need for dose monitoring solutions to make sure that patients received the right radiation doses while minimizing unnecessary exposure was directly impacted by the rise in demand for imaging services. The adoption of digital health technologies, such as dose monitoring software, was expedited by the pandemic. The increased value of digital dose monitoring tools was driven by healthcare providers' desire for remote patient data management and monitoring solutions.
The software segment is estimated to hold the largest share. Dose monitoring software refers to the specialized programs and applications designed to track, manage, and analyze radiation or medication doses administered to patients. This software is essential for guaranteeing accurate dosage administration, reducing hazards, and improving patient outcomes. It assists medical physicists and radiation oncologists in optimizing treatment regimens, guaranteeing that the tumor is successfully targeted while causing the least amount of harm to nearby healthy tissues. Radiation therapy is more accurate due to the software's real-time monitoring and adjustment features.
The diagnostic centers segment is anticipated to have lucrative growth during the forecast period. By restricting radiation exposure to safe levels, dose monitoring systems assist medical professionals in reducing the risk to their patients' health. By guaranteeing that the diagnostic imaging procedure is carried out in compliance with the advised dose levels and safety procedures, dose monitoring solutions help to ensure compliance with these regulations. Through the simplification of the data collection and reporting process, dose monitoring software can increase the effectiveness of diagnostic centers. In addition to guaranteeing radiation safety, this allows medical staff to concentrate on patient care.
North America commanded the largest market share during the extrapolated period. The key players in the dose monitoring market are the US and Canada. The region has a strong healthcare system and a high rate of uptake of cutting-edge medical technology. Healthcare organizations and providers in North America are pioneers in the adoption of state-of-the art medical technologies. In this area, dose monitoring is critical for both medication dosing in hospitals and radiation therapy used in cancer treatment. This region will continue to be a major force behind the global dose monitoring industry as regulations tighten and technology advances.
Europe is expected to witness profitable growth over the projection period, owing to its advanced healthcare infrastructure and rigorous regulatory environment. The demand for dose monitoring solutions is high because of the dedication to high-quality patient care that characterizes the European healthcare landscape. The use of cutting-edge technologies for dose monitoring has been fuelled by stricter laws and a focus on patient safety. Germany, one of the economic superpowers of Europe, boasts highly advanced medical facilities and a well-developed healthcare system.
Some of the key players in the Dose Monitoring Market include: GE Healthcare, Siemens Healthineers, Bayer AG, Mirion Technologies, Philips Healthcare, Varian Medical Systems, Sectra AB, Civco Medical Solutions, Nelco Worldwide and Medsquare.
In July 2023, Bayer and Peking University (PKU) collaborated to foster the translation of basic pharmaceutical research into drug discovery and development, while accelerating scientific research on cutting-edge technologies across the pharmaceutical value chain.
In February 2022, Siemens Healthineers and UNICEF partner to help improve access to healthcare in sub-Saharan Africa. The partnership will help optimize Point-of-Care (POC) diagnostics networks, strengthen health systems strained by the protracted pandemic and foster community engagement.